Baidu
map

J Endod:使用氢氧化钙、MTA和Biodentine对年轻龋坏恒牙实施直接盖髓术:一项临床随机试验

2017-09-19 lishiting MedSci原创

接盖髓治疗旨在保护牙髓活力,避免或减缓根尖孔开放病例的根管治疗,并促进牙根的持续发育。长久以来,氢氧化钙(CH)都是盖髓剂的金标准材料。但是,现今硅酸钙类材料(CSMs)由于其高生物学活性、生物相容性、封闭能力和机械性能,正逐渐取代CH。然而,还需要更多的临床随机试验来验证在直接盖髓操作中CSMs作为CH替代材料的适宜性。

直接盖髓治疗旨在保护牙髓活力,避免或减缓根尖孔开放病例的根管治疗,并促进牙根的持续发育。长久以来,氢氧化钙(CH)都是盖髓剂的金标准材料。但是,现今硅酸钙类材料(CSMs)由于其高生物学活性、生物相容性、封闭能力和机械性能,正逐渐取代CH。然而,还需要更多的临床随机试验来验证在直接盖髓操作中CSMs作为CH替代材料的适宜性。这项临床随机试验包含了169名来自于智利Maipo地区的患者(平均年龄为11.3岁)。所涉及的病患标准为一颗龋坏引起的牙髓暴露恒牙,并准备进行直接盖髓术治疗。患者随机分配至一个实验组(CH, Biodentine, 或MTA)。分别在术后1周, 3个月, 6个月和1年进行临床随访检查。使用Fisher精确检验进行统计学分析。术后1周的临床随访检查显示,所有患者均100%治疗成功。3个月时,CH组有1例治疗失败。6个月时,新增4例失败病例(CH组1例和MTA组3例)。1年时,CH组又多1例。然而,在实验组之间并不存在显著性差异。结论: CSMs看起来是一种可以替代CH的适宜材料。尽管在各研究组中未发现显著性差异,但Biodentine和MTA比CH要带来更多益处。原始

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2018-07-12 柳叶一刀
  2. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2018-01-11 傻妮

    棒棒的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-21 liuxiaona
  5. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-21 zhaozuguo
  9. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-20 明天会更好!

    很好!学习过了!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1917654, encodeId=1258191e6549c, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Jul 12 03:48:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277634, encodeId=c7ff2e7634a7, content=棒棒的, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=989f1678108, createdName=傻妮, createdTime=Thu Jan 11 22:56:29 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797580, encodeId=30781e975803d, content=<a href='/topic/show?id=6a5623080d7' target=_blank style='color:#2F92EE;'>#临床随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23080, encryptionId=6a5623080d7, topicName=临床随机试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Thu Apr 05 23:48:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368032, encodeId=3e981368032de, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435624, encodeId=81ff1435624d4, content=<a href='/topic/show?id=a84d342eac' target=_blank style='color:#2F92EE;'>#Biodentine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3427, encryptionId=a84d342eac, topicName=Biodentine)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512129, encodeId=14961512129f0, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569919, encodeId=242415699199e, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601247, encodeId=64b7160124e31, content=<a href='/topic/show?id=eb1b5282260' target=_blank style='color:#2F92EE;'>#恒牙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52822, encryptionId=eb1b5282260, topicName=恒牙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f418863982, createdName=zhaozuguo, createdTime=Thu Sep 21 09:48:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245821, encodeId=9824245821f6, content=很好!学习过了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Sep 20 00:30:20 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245746, encodeId=4ffb245e460c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRoMjVmFh7PMNtxpIv1A1s9EVvpF69WTWibNMGTTTozRQx7icIcicROpyS6OSKw9lHxDLFLOdfezCIibp/0, createdBy=fe331939879, createdName=1e0ebf30m03(暂无匿称), createdTime=Tue Sep 19 19:04:46 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-19 1e0ebf30m03(暂无匿称)

    学习了

    0

相关资讯

J Endod:一种新型生物活性玻璃盖髓材料的牙髓反应评估

这篇研究的目的是在应用一种新型生活活性玻璃(BG)盖髓材料实施直接盖髓后,体内评估牙髓对其的反应情况。

J Endod:使用TheraCal进行部分牙髓切断术后牙髓的反应:一项临床试验

对于含树脂的充填材料如TheraCal直接作用于牙髓的效力一直存有疑问。这篇研究的目的是为了评估应用TheraCal进行部分牙髓切断术的临床效力,并与Biodentine和ProRoot MTA相比较。

J Endod:盖髓材料引发的补体激活对炎症和牙髓干细胞募集效果显著

众所周知,补体,特别是通过C5a片段,可以促使炎症发生。近来,研究还发现它可以募集间充质干细胞参与再生。损伤或感染会引发局部牙髓成纤维细胞表达C5a。这篇研究的目的是为了检测不同盖髓生物材料的补体激活效果以及对炎症和牙髓干细胞募集的影响。

Baidu
map
Baidu
map
Baidu
map